NK Cell-Hydrogel Interactions
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring research services to assess Natural Killer cell interactions with hydrogels, with estimated solicitation release on May 1, 2027 and estimated award on September 1, 2027. This regulatory science effort addresses the safety and immune response evaluation of novel biomaterials used in cell manufacturing. The work falls under biological product manufacturing (NAICS 325414) with no set-aside applied.
The estimated award value ranges from $10,000 to $25,000. Inquiries may be directed to the FDA's Center for Biologics Evaluation and Research Acquisitions mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
Dedicated funds for assessing cell-material interactions, specifically how Natural Killer (NK) cells respond to various hydrogels. This is a critical regulatory science need for evaluating the safety and immune response of novel biomaterials that are used in cell manufacturing.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast